We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
110 hedge funds and large institutions have $854M invested in Revance Therapeutics, Inc. in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
14% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 29
7% more call options, than puts
Call options by funds: $2.08M | Put options by funds: $1.94M
0% more funds holding
Funds holding: 110 → 110 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
11% less capital invested
Capital invested by funds: $957M → $854M (-$103M)
Holders
110
Holders Change
–
Holders Change %
0%
% of All Funds
2.51%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
33
Reduced
29
Closed
13
Calls
$2.08M
Puts
$1.94M
Net Calls
+$139K
Net Calls Change
-$607K
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$14.1M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$11.9M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$9.3M |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$8.84M |
| 5 |
BlackRock
New York
|
+$7.15M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$29.8M |
| 2 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$16M |
| 3 |
Millennium Management
New York
|
-$12.3M |
| 4 |
O
OppenheimerFunds
New York
|
-$6.93M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$5.71M |
